Soligenix, Inc. is a late-stage biopharmaceutical company focused on developing products to treat the life-threatening side effects of cancer treatments and serious gastrointestinal diseases where, as well as developing several biodefense vaccines and therapeutics. The Company operates in two reportable segments: BioTherapeutics and BioDefense. The BioTherapeutics business segment intends to develop orBec ' (oral beclomethasone dipropionate, or oral BDP) and other biotherapeutic products, including LPM TM Leuprolide. The BioDefense business segment intends to convert its ricin toxin vaccine and radiation injury programs from early stage development to advanced development and manufacturing. Soligenix, Inc, formerly known as DOR BioPharma, Inc, is headquartered in Princeton, New Jersey.
Address Details
Address: 29 EMMONS DRIVE SUITE B-10
City: PRINCETON
State: NJ
Country: USA
Zip Code: 08540
Contact Details
609-538-8200
This weeks newsletter: 🚀 Retail Access to SpaceX, BlackBerry’s Big Moves, Trends to Watch 📈